Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Moberg signs distribution agreement with Pharmaplan in South Africa
As per the agreement Pharmaplan has exclusive rights to market and sell Nalox /Emtrix in South Africa. Moberg is responsible for production and supply of the product. Nalox
As per the agreement Pharmaplan has exclusive rights to market and sell Nalox /Emtrix in South Africa. Moberg is responsible for production and supply of the product. Nalox
The company may set up a manufacturing facility in Japan as a part of the joint venture agreement. The new JV will have 51% stake owned by Fujifilm
The FDA did not complete the review of Levadex’s new drug application, because of chemistry, manufacturing and controls issues observed during an inspection of the third-party manufacturer, the
Both the partners signed a new strategic agreement to collaborate in the area of biomedical sciences over the next three years. BTC was established by Bayer HealthCare and
The solution leverages LabConnect’s software, SampleREACH, which provides web-based sample tracking including collection, shipment, and receipt at any laboratory or location worldwide. The software enables instant accessioning and
The automated software systems will replace previous manual, paper-based CAPA and complaints processes, the Pharmaceutical Associates said. Pilgrim’s CAPA Management and Complaints Management form a closed-loop system that
Study 11565 administered 183 patients with one of five different dose regimens of SAR236553/REGN727, either 50mg, 100mg, or 150mg Q2W, or 200mg or 300mg Q4W alternating with placebo
The new site includes 800m² for discovery and process development through new laboratory, piloting and FAT testing areas. By increasing the engineering capabilities, Novasep will expand output for
Impax Laboratories president and CEO Larry Hsu said in the past two years, the company has entered into four distinct partnerships for alternative dosage form products. "Our business
Under the agreement, Hanmi will be in charge of formulation research, early clinical studies and manufacturing, and GSK will be in charge of late stage clinical studies and